See You in New Orleans
Join Fresenius Medical Care and thousands of kidney professionals from across the globe at the American Society of Nephrology’s Kidney Week 2017, scheduled this year from October 31 through November 5, 2017, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The annual symposium is the largest and most influential gathering of kidney professionals in the world, drawing more than 13,000 physicians, scientists and healthcare professionals from over 100 countries, this year featuring over 75 research abstracts in poster and oral presentations by Fresenius Medical Care researchers and clinical experts.
Let’s share ideas
The annual Kidney Week symposium is an exciting opportunity to share expertise, learn about the latest scientific and medical advances and to engage with top experts in the field. Attend one of our many different presentations by Fresenius Medical Care researchers and clinical experts. Browse the American Society of Nephrology’s database of abstracts or download our Fresenius Medical Care 2017 ASN Kidney Week guide, listing all Fresenius Medical Care-affiliated research presentations, including topics, times and locations.
Stop by for a chat
Visit our booths to meet our expert teams and learn more about the products and services offered by our family of companies.
Acumen Physician Solutions provides innovative and intuitive cloud-based solutions to assist nephrologists in the practice of medicine. As a service based organization, Acumen continues to thrive by providing an outstanding customer experience to renal providers, practices and patients. Our nephrology-specific products include: Acumen Mobile Charge Capture, Acumen nEHR, Acumen Plus (nEHR+PM), Acumen Practice Management, Acumen Nephrologixx, and Acumen PQRS.
Frenova Renal Research is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. Frenova manages a networked system of clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 medical practices. Frenova manages clinical trials in kidney disease and its adjacent medical conditions.
Fresenius Kidney Care provides dialysis treatment and services to more than 180,000 patients with kidney disease at more than 2,200 facilities nationwide. Fresenius Kidney Care supports people by helping to address both the physical and emotional aspects of kidney disease through personalized care, education and lifestyle support services so they can lead meaningful and fulfilling lives. For more information about Fresenius Kidney Care, visit www.freseniuskidneycare.com.
Fresenius Renal Pharmaceuticals is the partner of choice for biotech and pharmaceutical companies seeking to provide pharmaceutical treatment to CKD patients. The pharmaceuticals team collaborates closely with the CKD community to market, educate, and distribute vital pharmaceutical therapies through a model focused on serving the CKD community with innovative products and services. Key offerings include: Velphoro® (the first non-calcium, iron-based chewable phosphate binder for the control of serum phosphorus levels in patients with CKD on dialysis), Venofer® (an iron sucrose injection providing first-line IV therapy for the treatment of iron deficiency anemia in patients with CKD), and Phoslyra® (a calcium acetate oral solution indicated for the reduction of serum phosphorus in patients with ESRD).
Fresenius Renal Technologies provides in-center (clinical) and home dialysis products in support of nearly 200,000 patients battling CKD and ERSD. Key offerings include Optiflux® dialyzers (the most prescribed brand in the market), Crit-Line® (revolutionary fluid management technology), 2008T Hemodialysis Machines (in-center hemodialysis), 2008K@home™ Hemodialysis Machines (home hemodialysis) and Liberty® Cyclers (home peritoneal dialysis), as well as ancillary products, including bloodlines and concentrates.
Spectra Laboratories delivers renal-specific testing, analysis and reporting with the reliability required to ensure the best outcomes possible for patients. The company provides on-site training and education by certified renal professionals and an extensive courier network. Spectra also has bicoastal operations with dedicated start-up, IT and customer support teams who are ready to address client needs. Spectra’s fully integrated ordering and reporting application, Korus™, helps physicians comply with industry guidelines and our spectra@home™ application provides patients direct access to their lab results.
RRI is a unique research organization that stands at the forefront of medical research in chronic kidney disease, particularly in patients undergoing renal replacement therapies. The Institute has been a leading force behind landmark studies on hemodialysis, and has a solid and successful partnership with national and international academic institutions. RRI research spans a full spectrum of interests from molecular biology to clinical research and epidemiology. RRI hosts a distinguished annual International Conference on Dialysis and trains research fellows from over 30 countries around the world.